SLC25A6 and glioblastoma: We employed bioinformatics analysis, targeted mass spectrometry, RT‐PCR, immunoblotting, and assessment of cellular energy state to elucidate how individual ANT isoforms are expressed during the development of senescence in noncancerous and glioblastoma cells.